CLINICAL TRIAL

Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic Seizures

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: ClinicalTrials.gov
Date: 2025-08-21
Source: ClinicalTrials.gov
DOI: Unavailable
PubMed: Unavailable

Authors

Centre Hospitalier Universitaire de Nīmes

Watch author

Derived topics and classifications

psilocybin Default Mode Network Emotional Processing Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psilocybin-facilitated Treatment for Cocaine UseClinicalTrials.gov · 2026-05-18 Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging StudyClinicalTrials.gov · 2025-08-20 Psilocybin in Alcohol Use Disorder With Comorbid DepressionClinicalTrials.gov · 2025-03-19 Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major DepressionClinicalTrials.gov · 2022-04-29 Probing the Functional Magnetic Resonance Imaging Response to Psilocybin in Functional Neurological Disorder (PsiFUND)ClinicalTrials.gov · 2026-07-23 Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy SubjectsClinicalTrials.gov · 2026-06-25 A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy VolunteersClinicalTrials.gov · 2026-02-13 Precision Functional Brain Mapping to Understand the Mechanisms of PsilocybinClinicalTrials.gov · 2025-10-31